文献速递淋巴瘤

肝脾T细胞淋巴瘤:一种罕见但具有挑战性的疾病

Hepatosplenic T-cell lymphoma: a rare but challenging entity.
PubMed 文献 · Blood · 2020-01-01

肝脾T细胞淋巴瘤(HSTCL)是一种罕见的T细胞肿瘤,多起源于表达γ/δ T细胞受体的小部分淋巴细胞,常见于青少年和年轻成人,临床病程进展迅速且对常规化疗方案难治,预后差。约20%的病例发生于慢性免疫抑制或免疫失调背景。本文综述其临床和病理特征,并总结近期分子研究结果提示的新型治疗策略潜在靶点。

要点

  • HSTCL多见于青少年和年轻成人,临床病程进展迅速,对常规化疗难治,预后差。
  • 约20%的病例发生于慢性免疫抑制或免疫失调背景。
  • 常见染色体异常为等臂染色体7q和8号染色体三体,多数病例存在染色质修饰或JAK/STAT通路基因突变。

核心结论

  • HSTCL是一种罕见但诊断具有挑战性的淋巴瘤,因缺乏淋巴结受累且表现症状可模仿包括感染性病因在内的不同疾病。
  • 近期分子研究结果提示了新型治疗策略的潜在靶点。

研究设计与样本

  • 综述,总结HSTCL的临床和病理特征以及近期分子研究结果。

主要发现

  • HSTCL是一种罕见的T细胞肿瘤,最常起源于表达γ/δ T细胞受体的小部分淋巴细胞。
  • HSTCL在青少年和年轻成人中更常见,临床病程进展迅速,对常规化疗方案难治,预后差。
  • 约20%的病例发生于慢性免疫抑制或免疫失调背景。
  • 患者常表现为全身症状、肝脾肿大和血细胞减少;也可发生噬血细胞综合征。
  • 与HSTCL相关的最常见染色体异常为等臂染色体7q和8号染色体三体,多数病例存在染色质修饰或JAK/STAT通路基因突变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly arises from a small subset of γ/δ T-cell receptor-expressing lymphocytes. HSTCL is more common in adolescent and young adults and has a rapidly progressive clinical course and poor outcome due to its refractoriness to conventional chemotherapy regimens. Approximately 20% of the cases arise in the background of chronic immunosuppression or immune dysregulation. Patients commonly present with constitutional symptoms, hepatic and liver enlargement, and cytopenias; hematophagocytic syndrome can also occur. The most frequent chromosomal aberrations associated with HSTCL are isochromosome 7q and trisomy 8, and most cases harbor mutations in genes involved in chromatin modification or the JAK/STAT pathway. The rarity of this disease, along with lack of nodal involvement and presenting symptoms that mimic different entities including infectious etiologies, makes this lymphoma a significant diagnostic challenge. In this review, we highlight the clinical and pathologic features of HSTCL. Moreover, we summarize the results of recent molecular studies suggesting potential targets for novel therapeutics strategies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Pro B, Allen P, Behdad A, et al. Hepatosplenic T-cell lymphoma: a rare but challenging entity. Blood. 2020. PMID: 32756940. doi:10.1182/blood.2019004118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。